Quantbot Technologies’s Trillium Therapeutics TRIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-6,900
Closed -$121K – 2080
2021
Q3
$121K Buy
+6,900
New +$80.6K 0.01% 918

Other funds holding TRIL

Quantbot Technologies's TRIL Position: Q4 2021 in Review

Quantbot Technologies sold out of Trillium Therapeutics (TRIL) in Q4 2021, closing a stake of 6,900 shares — an estimated $121K sold.

Quantbot Technologies first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $121K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

  • Quantbot Technologies reported no remaining Trillium Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Quantbot Technologies sold 6,900 Trillium Therapeutics shares in Q4 2021, an estimated $121K.
  • Quantbot Technologies first reported a position in Trillium Therapeutics in Q3 2021 and held it in 1 quarter.
  • Quantbot Technologies's Trillium Therapeutics position peaked at $121K in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Trillium Therapeutics as of Q4 2021.

Based on Quantbot Technologies's 13F filing for Q4 2021, filed 11 Feb 2022.